0002076369-25-000001.txt : 20250715 0002076369-25-000001.hdr.sgml : 20250715 20250714175855 ACCESSION NUMBER: 0002076369-25-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20250715 DATE AS OF CHANGE: 20250714 EFFECTIVENESS DATE: 20250715 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DSIpharma, Inc. CENTRAL INDEX KEY: 0002076369 ORGANIZATION NAME: EIN: 392901038 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-551710 FILM NUMBER: 251122609 BUSINESS ADDRESS: STREET 1: 251 LITTLE FALLS DRIVE CITY: WILMINGTON STATE: DE ZIP: 19808 BUSINESS PHONE: 866-403-5272 MAIL ADDRESS: STREET 1: 999 THIRD AVENUE STREET 2: SUITE 3900 CITY: SEATTLE STATE: WA ZIP: 98104-4076 D 1 primary_doc.xml X0708 D LIVE 0002076369 DSIpharma, Inc. 251 LITTLE FALLS DRIVE WILMINGTON DE DELAWARE 19808 866-403-5272 DELAWARE None None Corporation true 2025 Mark Ridall 251 Little Falls Drive Wilmington DE DELAWARE 19808 Executive Officer Director Kysha Ayana Pierre-Louis 251 Little Falls Drive Wilmington DE DELAWARE 19808 Executive Officer Director Other Health Care Decline to Disclose 06b false 2025-06-17 false true false 0 500000 45000 455000 false 1 0 0 0 false DSIpharma, Inc. /s/ Kysha Pierre-Louis Kysha Pierre-Louis President & Chief Financial Officer 2025-07-14